Biopsy Neutrophilia, Neutrophil Chemokine and Receptor Gene Expression in Severe Exacerbations of Chronic Obstructive Pulmonary Disease

American Journal of Respiratory and Critical Care Medicine

Volumn 168, Issue 8, 2003, Pages 968-975

  Qiu, Yusheng ^b   Zhu, Jie ^b   Bandi, Venkata ^b   Atmar, Robert L ^b   Hattotuwa, Keith ^b   Guntupalli, Kay K ^b   Jeffery, Peter K ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Chemokines; COPD; CXCL5, CXCL8, CXCR1, CXCR2; Neutrophils

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CXCR1; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; INTERLEUKIN 8; MESSENGER RNA;

ACUTE DISEASE; ADULT; ARTICLE; BRONCHUS BIOPSY; CELL COUNT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE EXACERBATION; ENDOTRACHEAL INTUBATION; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOHISTOLOGY; IN SITU HYBRIDIZATION; MALE; MUCOSA; NEUTROPHILIA; PRIORITY JOURNAL; RECEPTOR GENE; SAMPLING; SMOKING; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; VIRUS INFECTION;

ACUTE DISEASE; AGED; BIOPSY; BRONCHOSCOPY; CASE-CONTROL STUDIES; CHEMOKINES, CXC; FEMALE; FORCED EXPIRATORY VOLUME; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATION; INTERLEUKIN-8; MALE; MIDDLE AGED; NEUTROPHIL INFILTRATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, INTERLEUKIN-8A; RECEPTORS, INTERLEUKIN-8B; RESPIRATORY MUCOSA; SEVERITY OF ILLNESS INDEX; UP-REGULATION;

EID: 0142043976     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200208-794OC     Document Type: Article

References (55)

1. Pauwels R, Anthonisen N, Barnes PJ, Buist AS, Calverley CP, Fukuchi Y, Grouse L, Hogg JC, Jenkins C, Postma DS, et al. Global initiative for chronic obstructive lung disease. Bethesda, MD: National Heart, Lung, and Blood Institute, National Institutes of Health; 2001.
2. Osman LM, Godden DJ, Friend JAR, Legge JS, Douglas JG. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. Thorax 1997;52:67-71.
3. Jeffery PK. Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 2001;164:S28-S38.
4. Saetta M, Turato G, Maestrelli P, Mapp CE, Fabbri LM. Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:1304-1309.
5. Peinado VI, Barbera JA, Abate P, Ramirez J, Roca J, Santos S, Rodriguez-Roisin R. Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:1605-1611.
6. 1. Am J Respir Crit Care Med 1997; 155:852-857.
7. Saetta M, Di Stefano A, Maestrelli P, Ferraresso A, Drigo R, Potena A, Ciaccia A, Fabbri LM. Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis 1993;147:301-306.
8. Lams BE, Sousa AR, Rees PJ, Lee TH. Subepthelial immunopathology of large airways in smokers with and without chronic obstructive pulmonary disease. Eur Respir J 2000;15:512-516.
9. Jeffery PK. Comparison of the structural and inflammatory features of COPD and asthma: Giles F. Filley Lecture. Chest 2000;117:251s-260s.
10. Saetta M, Di Stefano A, Maestrelli P, Turato G, Ruggieri MP, Roggeri A, Calcagni P, Mapp CE, Ciaccia A, Fabbri LM. Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med 1994;150:1646-1652.
11. Di Stefano A, Capelli A, Lusuardi M, Balbo P, Vecchio C, Maestrelli P, Mapp CE, Fabbri L, Donner CF, Saetta M. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med 1998;158:1277-1285.
12. Balbi B, Bason C, Balleari E, Fiasella F, Pesci A, Ghio R, Fabiano F. Increased bronchoalveolar granulocytes and granulocyte/macrophage colony-stimulating factor during exacerbations of chronic bronchitis. Eur Respir J 1997;10:846-850.
13. Aaron SD, Angel JB, Lunau M, Wright K, Fex C, Le Saux N, Dales RE. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:349-355.
14. Maestrelli P, Saetta M, Di Stefano A, Calcagni PG, Turato G, Ruggieri MP, Roggeri A, Mapp CE, Fabbri LM. Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage. Am J Respir Crit Care Med 1995;152:1926-1931.
15. Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;161: 1608-1613.
16. Wedzicha JA. Mechanisms of exacerbations. Novartis Found Symp 2001; 234:84-93.
17. Gompertz S, Stockley RA. Inflammation-role of the neutrophil and the eosinophil. Semin Respir Infect 2000;15:14-23.
18. Turato G, Zuin R, Miniati M, Baraldo S, Rea F, Beghe B, Monti S, Formichi B, Boschetto P, Harari S, et al. Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema. Am J Respir Crit Care Med 2002; 166:105-110.
19. Zhu J, Qiu YS, Majumdar S, Gamble E, Matin D, Turato G, Fabbri LM, Barnes N, Saetta M, Jeffery PK. Bronchial eosinophilia and gene expression for IL-4, IL-5, and eosinophil chemoattractants in bronchitis. Am J Respir Crit Care Med 2001;164:109-116.
20. Panina-Bordignon P, D'Ambrosio D. Chemokines and their receptors in asthma and chronic obstructive pulmonary disease. Curr Opin Pulm Med 2003;9:104-110.
21. Owen C. Chemokine receptors in airway disease: which receptors to target? Pulm Pharmacol Ther 2001;14:193-202.
22. Strieter RM, Lukacs NW, Standiford TJ, Kunkel SL. Cytokines. 2. Cytokines and lung inflammation: mechanisms of neutrophil recruitment to the lung. Thorax 1993;48:765-769.
23. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000;12:121-127.
24. Strieter RM. Interleukin-8: a very important chemokine of the human airway epithelium. Am J Physiol Lung Cell Mol Physiol 2002;283:L688-L689.
25. Imaizumi T, Albertine KH, Jicha DL, McIntyre TM, Prescott SM, Zimmerman GA. Human endothelial cells synthesize ENA-78: relationship to IL-8 and to signaling of PMN adhesion. Am J Respir Cell Mol Biol 1997;17:181-192.
26. Wuyts A, Proost P, Van Damme J. Interleukin-8 and other CXC chemokines. In: Thomson A, editor. The cytokine handbook, 3rd ed. San Diego, CA: Academic Press; 2001. p. 271-311.
27. Saetta M, Mariani M, Panina-Bordignon P, Turato G, Buonsanti C, Baraldo S, Bellettato CM, Papi A, Corbetta L, Zuin R, et al. Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;165:1404-1409.
28. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002;57:847-852.
29. Seemungal T, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, Message S, Maccallum P, Meade TW, Jeffries DJ, Johnston SL, et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:1618-1623.
30. Qiu YS, Zhu J, Bandi V, Fraire AE, Guntupalli KK, Jeffery PK. Neutrophil chemokine receptor (CXCR1 and 2) gene expression and biopsy neutrophilia in severe exacerbations of chronic obstructive pulmonary disease (COPD) [abstract]. Eur Respir J 2001;18:501s.
31. Qiu YS, Zhu J, Bandi V, Fraire AE, Hattotuwa K, Guntupalli KK, Jeffery PK. Endobronchial biopsy neutrophilia, IL-8, ENA-78 and neutrophil chemokine receptor (CXCR1 and CXCR2) gene expression in severe exacerbations of COPD [abstract]. Eur Respir J 2002;20:377s.
32. Bandi V, Apicella MA, Mason E, Murphy TF, Siddiqi A, Atmar RL, Greenberg SB. Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis. Am J Respir Crit Care Med 2001;164:2114-2119.
33. Atmar RL, Guy E, Guntupalli KK, Zimmerman JL, Bandi VD, Baxter BD, Greenberg SB. Respiratory tract viral infections in inner-city asthmatic adults. Arch Intern Med 1998;158:2453-2459.
34. Wilkinson DG. In situ hybridization: a practical approach. Oxford: Oxford University Press; 1992.
35. Aherne WA, Dunnill MS. Point counting and morphometry. In: Aherne WA, Dunnill MS, editors. Morphometry. London: E. Arnold; 1982. p. 33-45.
36. Lee J, Horuk R, Rice GC, Bennett GL, Camerato T, Wood WI. Characterization of two high-affinity human interleukin-8 receptors. J Biol Chem 1992;267:16283-16287.
37. Chuntharapai A, Kim KJ. Regulation of the expression of IL-8 receptor A/ B by IL-8: possible functions of each receptor. J Immunol 1995;155: 2587-2594.
38. Wuyts A, Van Osselaer N, Haelens A, Samson I, Herdewijn P, Ben Baruch A, Oppenheim JJ, Proost P, Van Damme J. Characterization of synthetic human granulocyte chemotactic protein 2: usage of chemokine receptors CXCR1 and CXCR2 and in vivo inflammatory properties. Biochemistry 1997;36:2716-2723.
39. de Boer WI, Sont JK, van Schadewijk A, Stolk J, van Krieken JH, Hiemstra PS. Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD. J Pathol 2000;190:619-626.
40. Walz A, Burgener R, Car B, Baggiolini M, Kunkel SL, Strieter RM. Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8. J Exp Med 1991; 174:1355-1362.
41. Lukacs NW, Kunkel SL, Allen R, Evanoff HL, Shaklee CL, Sherman JS, Burdick MD, Strieter RM. Stimulus and cell-specific expression of C-X-C and C-C chemokines by pulmonary stromal cell populations. Am J Physiol 1995;268:L856-L861.
42. Kruger T, Baier J. Induction of neutrophil chemoattractant cytokines by Mycoplasma hominis in alveolar Type II cells. Infect Immun 1997;65: 5131-5136.
43. Bozic CR, Gerard NP, Gerard C. Receptor binding specificity and pulmonary gene expression of the neutrophil-activating peptide ENA-78. Am J Respir Cell Mol Biol 1996;14:302-308.
44. Colletti LM, Kunkel SL, Walz A, Burdick MD, Kunkel RG, Wilke CA, Strieter RM. Chemokine expression during hepatic ischemia/reperfusion-induced lung injury in the rat: the role of epithelial neutrophil activating protein. J Clin Invest 1995;95:134-141.
45. Goodman RB, Strieter RM, Martin DP, Steinberg KP, Milberg JA, Maunder RJ, Kunkel SL, Walz A, Hudson LD, Martin TR. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1996;154:602-611.
46. Keane MP, Belperio JA, Burdick MD, Lynch JP, Fishbein MC, Strieter RM. ENA-78 is an important angiogenic factor in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001;164:2239-2242.
47. Arenberg DA, Keane MP, DiGiovine B, Kunkel SL, Morris SB, Xue YY, Burdick MD, Glass MC, Iannettoni MD, Strieter RM. Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer. J Clin Invest 1998;102:465-472.
48. Lamblin C, Gosset P, Tillie-Leblond I, Saulnier F, Marquette CH, Wallaert B, Tonnel AB. Bronchial neutrophilia in patients with noninfectious status asthmaticus. Am J Respir Crit Care Med 1998;157:394-402.
49. Ordonez CL, Shaughnessy TE, Matthay MA, Fahy JV. Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: clinical and biological significance. Am J Respir Crit Care Med 2000;161:1185-1190.
50. Tillie-Leblond I, Pugin J, Marquette CH, Lamblin C, Saulnier F, Brichet A, Wallaert B, Tonnel AB, Gosset P. Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. Am J Respir Crit Care Med 1999;159:487-494.
51. Wenzel SE, Szefler SJ, Leung DYM, Sloan SI, Rex MD, Martin RJ. Bronchoscopic evaluation of severe asthma: persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med 1997;156:737-743.
52. Cox G. Glucocorticoid treatment inhibits apoptosis in human neutrophils: separation of survival and activation outcomes. J Immunol 1995;154: 4719-4725.
53. Meagher LC, Cousin JM, Seckl JR, Haslett C. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 1996;156:4422-4428.
54. Fahy JV, Kim KW, Liu J, Boushey HA. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol 1995;95:843-852.
55. Gamble E, Pavord I, Vignola AM, Kroegel C, Morell F, Hansell TT, Compton C, Troy S, Edelson JD, Amit O, et al. Inflammatory cell quantification in bronchial biopsies (BB) in COPD: evaluation to 100 microns depth vs. all intact subepithelium. Eur Respir J 2002; 20(Suppl):403s.